SCHEMBL8559709

SCHEMBL8559709

CCCCCC(c1cccc2c1C(=O)NC2=O)C1CNCCO1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 14/20 0.36
SLC6A4 P31645 13/20 0.36
SLC6A3 Q01959 8/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
ADRB2 P07550 2/20 0.36
MLNR O43193 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2C P28335 1/20 0.36
OPRK1 P41145 1/20 0.36
KCNH2 Q12809 1/20 0.36
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8558961 0.89 SLC6A2 (0.32) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL8556232 0.80 SSTR4 (0.37) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL8559801 0.75 SLC6A2 (0.35) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL8555645 0.73 SLC6A2 (0.33) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL10731506 0.72 CYSLTR2 (0.39) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6033869 0.72 KDM4E (0.38) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL10384426 0.71 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL28620531 0.70 KDM4E (0.37) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8815302 0.69 MEN1 (0.37) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL30608966 0.69 KDM4E (0.36) KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575954-B1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI SRL (IT) 1998-09-02 EP disclosed
US-5424451-A Used as cholinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1995-06-13 US disclosed
US-5302593-A Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1994-04-12 US disclosed
EP-0575954-A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1993-12-29 EP disclosed